Cash flow Shandong Sanyuan Biotechnology Co.,Ltd.

Equities

301206

CNE100005774

Food Processing

End-of-day quote Shenzhen S.E. Other stock markets 06/03/2026			5-day change	1st Jan Change
27.37 ^CNY	+2.51%		-4.13%	+4.11%

10/02	Certain A Shares of Shandong Sanyuan Biotechnology Co.,Ltd. are subject to a Lock-Up Agreement Ending on 10-FEB-2026.	CI
14/11	Shandong Sanyuan Biotechnology Co.,Ltd. Approves Cash Dividend for the Third Quarter of 2025	CI

616957d0680468.DSktT__GUqD_4YHHR9LHfYMknn5vFhT5iMb0Sakq6Ds.WxBPAJqeZ82V0OOeF7G1D7FGqRoFYHWR5JayDZleo0h_S3oAp5EY9qWG1A

Published financial data: SHANDONG SANYUAN BIOTECHNOLOGY CO.,LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	77Cr	164.14Cr	66Cr	48Cr	70Cr
Other Revenues, Total	1.05Cr	3.39Cr	1.91Cr	1.68Cr	1.44Cr
Total Revenues	78Cr	167.53Cr	67Cr	50Cr	71Cr
Cost of Goods Sold, Total	45Cr	97Cr	59Cr	49Cr	64Cr
Gross Profit	33Cr	70Cr	8.79Cr	1.4Cr	7.75Cr
Selling General & Admin Expenses, Total	1.4Cr	1.88Cr	2.03Cr	2.01Cr	2.5Cr
Provision for Bad Debts	-62.87T	4L	-2L	51.77T	6L
R&D Expenses	3.03Cr	5.9Cr	3.41Cr	5.07Cr	4.12Cr
Other Operating Expenses	50.31L	70.07L	32.11L	25.45L	28.76L
Other Operating Expenses, Total	4.93Cr	8.52Cr	5.73Cr	7.33Cr	6.98Cr
Operating Income	28Cr	62Cr	3.06Cr	-5.93Cr	77.07L
Interest Expense, Total	-	-943	-	-	-
Interest And Investment Income	25.09L	35.01L	10Cr	12Cr	11Cr
Net Interest Expenses	25.09L	35L	10Cr	12Cr	11Cr
Currency Exchange Gains (Loss)	-1.13Cr	-74.73L	4.28Cr	26.83L	74.55L
Other Non Operating Income (Expenses)	-4L	-7L	-3L	-2L	-3L
EBT, Excl. Unusual Items	27Cr	61Cr	17Cr	6.03Cr	13Cr
Gain (Loss) On Sale Of Investments	-	3L	-3L	-	-
Gain (Loss) On Sale Of Assets	-3L	-6L	-	-	-
Asset Writedown	-27.03L	-5.7T	-2L	-	-68.2T
Other Unusual Items	25.16L	86.79L	1.1Cr	14.04L	19.58L
EBT, Incl. Unusual Items	27Cr	62Cr	18Cr	6.17Cr	13Cr
Income Tax Expense	3.76Cr	8.45Cr	2.03Cr	28.37L	2.33Cr
Earnings From Continuing Operations	23Cr	54Cr	16Cr	5.89Cr	10Cr
Net Income to Company	23Cr	54Cr	16Cr	5.89Cr	10Cr
Net Income - (IS)	23Cr	54Cr	16Cr	5.89Cr	10Cr
Net Income to Common Incl Extra Items	23Cr	54Cr	16Cr	5.89Cr	10Cr
Net Income to Common Excl. Extra Items	23Cr	54Cr	16Cr	5.89Cr	10Cr
Per Share Items
Net EPS - Basic	1.53	3.53	0.82	0.29	0.52
Basic EPS - Continuing Operations	1.53	3.53	0.82	0.29	0.52
Basic Weighted Average Shares Outstanding	15Cr	15Cr	20Cr	20Cr	20Cr
Net EPS - Diluted	1.53	3.53	0.82	0.29	0.52
Diluted EPS - Continuing Operations	1.53	3.53	0.82	0.29	0.52
Diluted Weighted Average Shares Outstanding	15Cr	15Cr	20Cr	20Cr	20Cr
Normalized Basic EPS	1.12	2.52	0.54	0.19	0.39
Normalized Diluted EPS	1.12	2.52	0.54	0.19	0.39
Dividend Per Share	0.47	0.67	0.7	0.25	1.4
Payout Ratio	30.45	-	82.4	243.16	77.08
Supplemental Items
EBITDA	30Cr	64Cr	6.93Cr	3L	7.39Cr
EBITA	28Cr	62Cr	3.17Cr	-5.82Cr	88.07L
EBIT	28Cr	62Cr	3.06Cr	-5.93Cr	77.07L
EBITDAR	-	64Cr	7.03Cr	13.17L	7.5Cr
Total Revenues (As Reported)	-	167.53Cr	67Cr	50Cr	71Cr
Effective Tax Rate - (Ratio)	13.91	13.63	11.02	4.6	18.14
Total Current Taxes	-	7.29Cr	-	-	-
Total Deferred Taxes	-	1.16Cr	2.03Cr	28.37L	2.33Cr
Normalized Net Income	17Cr	38Cr	11Cr	3.77Cr	7.89Cr
Non-Cash Pension Expense	-	4L	-	-	-
Supplemental Operating Expense Items
Advertising Expense	7L	10.76L	7L	11.66L	12.58L
Selling and Marketing Expenses	38.86L	54.68L	51.94L	55.83L	69.67L
General and Administrative Expenses	1.01Cr	1.33Cr	1.51Cr	1.45Cr	1.81Cr
Research And Development Expense From Footnotes	3.03Cr	5.9Cr	3.41Cr	5.07Cr	4.13Cr
Net Rental Expense, Total	-	7L	10.49L	10.5L	10.5L
Maintenance & Repair Expenses, Total	18.64L	20.68L	17.59L	10.58L	16.68L

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	22Cr	52Cr	49Cr	11Cr	16Cr
Short Term Investments	-	-	-	-	267Cr
Trading Asset Securities, Total	-	3L	-	-	-
Total Cash And Short Term Investments	22Cr	52Cr	49Cr	11Cr	283.03Cr
Accounts Receivable, Total	7.09Cr	14Cr	5.11Cr	8.09Cr	12Cr
Other Receivables	88.84L	2.01Cr	1.28Cr	1.66Cr	28Cr
Total Receivables	7.98Cr	16Cr	6.39Cr	9.75Cr	40Cr
Inventory	6.82Cr	11Cr	9.68Cr	10Cr	14Cr
Prepaid Expenses	-	-	-	-	-
Other Current Assets, Total	56.75L	1.59Cr	1.96Cr	1.11Cr	1.51Cr
Total Current Assets	38Cr	81Cr	67Cr	32Cr	338.8Cr
Gross Property Plant And Equipment	40Cr	83Cr	105.09Cr	114.14Cr	125.92Cr
Accumulated Depreciation	-3.76Cr	-6.19Cr	-9.79Cr	-15Cr	-21Cr
Net Property Plant And Equipment	36Cr	77Cr	95Cr	99Cr	104.73Cr
Long-term Investments	-	-	6.02Cr	5.89Cr	5.32Cr
Other Intangibles, Total	3.01Cr	4.91Cr	4.87Cr	4.76Cr	4.64Cr
Deferred Tax Assets Long-Term	24.14L	25.18L	-	-	-
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	58.57L	62.74L	313.87Cr	339.49Cr	27Cr
Total Assets	78Cr	163.42Cr	486.99Cr	481.04Cr	480.53Cr
Liabilities
Accounts Payable, Total	24Cr	54Cr	18Cr	21Cr	18Cr
Accrued Expenses, Total	41.75L	67.14L	93L	76.93L	86.46L
Short-term Borrowings	-	-	-	-	-
Current Income Taxes Payable	43.57L	34L	-	-	4
Unearned Revenue Current, Total	1.11Cr	1.14Cr	42.18L	51.78L	48.16L
Other Current Liabilities	4L	8L	96.79L	27.54L	5.45Cr
Total Current Liabilities	26Cr	56Cr	21Cr	22Cr	24Cr
Unearned Revenue Non Current	12.23L	10L	9L	45.93L	35.09L
Deferred Tax Liability Non Current	1.14Cr	2.3Cr	4.08Cr	4.36Cr	6.69Cr
Total Liabilities	27Cr	59Cr	25Cr	27Cr	31Cr
Common Stock, Total	10Cr	10Cr	20Cr	20Cr	20Cr
Additional Paid In Capital	7.21Cr	7.21Cr	351.76Cr	351.76Cr	351.76Cr
Retained Earnings	34Cr	87Cr	90Cr	82Cr	79Cr
Treasury Stock	-	-	-	-	-1.76Cr
Total Common Equity	51Cr	104.53Cr	462.08Cr	453.8Cr	449.12Cr
Total Equity	51Cr	104.53Cr	462.08Cr	453.8Cr	449.12Cr
Total Liabilities And Equity	78Cr	163.42Cr	486.99Cr	481.04Cr	480.53Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	15Cr	20Cr	20Cr	20Cr	20Cr
ECS Total Common Shares Outstanding	15Cr	15Cr	20Cr	20Cr	20Cr
Book Value / Share	3.36	6.89	22.84	22.43	22.41
Tangible Book Value	48Cr	100Cr	457.2Cr	449.04Cr	444.48Cr
Tangible Book Value Per Share	3.16	6.56	22.6	22.19	22.17
Total Debt	0	0	0	0	0
Net Debt	-22Cr	-52Cr	-49Cr	-11Cr	-283.03Cr
Debt Equivalent Oper. Leases	-	57.59L	83.92L	83.97L	83.97L
Equity Method Investments, Total	-	-	6.02Cr	5.89Cr	5.32Cr
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	95.15L	3.4Cr	1.97Cr	1.58Cr	2.25Cr
Inventories - Work In Process, Total	2.61Cr	4.07Cr	4.96Cr	5.1Cr	6.65Cr
Inventories - Finished Goods, Total	3.26Cr	3.75Cr	3.27Cr	1.15Cr	5.37Cr
Inventories - Others	-	-	-	2.62Cr	-
Buildings, Total	6.2Cr	6.5Cr	14Cr	17Cr	22Cr
Machinery, Total	26Cr	41Cr	79Cr	86Cr	99Cr
Full Time Employees	270	382	460	427	436
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	1.34T	48.73T	7L

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	23Cr	54Cr	16Cr	5.89Cr	10Cr
Depreciation & Amortization - CF	1.62Cr	2.49Cr	3.76Cr	5.85Cr	6.51Cr
Amortization of Goodwill and Intangible Assets - (CF)	7L	7L	10.89L	11L	10.99L
Depreciation & Amortization, Total	1.69Cr	2.56Cr	3.87Cr	5.96Cr	6.62Cr
Amortization of Deferred Charges, Total - (CF)	-	10.32T	27.8T	52.27T	51.41T
(Gain) Loss From Sale Of Asset	3L	6L	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-4L	-3L	-8.61Cr	-11Cr	-11Cr
Asset Writedown & Restructuring Costs	27.03L	5.7T	53.91L	-	68.2T
Provision and Write-off of Bad Debts	-62.9T	4L	-2L	51.77T	6L
Other Operating Activities, Total	45.9L	12.18L	-	2L	-
Change In Accounts Receivable	-14Cr	-17Cr	9.81Cr	-9.79Cr	-4.22Cr
Change In Inventories	-2.23Cr	-4.4Cr	1.02Cr	-25.32L	-3.84Cr
Change In Accounts Payable	11Cr	28Cr	-17Cr	15Cr	-1.97Cr
Change In Deferred Taxes	61.04L	1.16Cr	2.03Cr	28.37L	2.33Cr
Cash from Operations	22Cr	64Cr	8.43Cr	5.73Cr	-1.36Cr
Capital Expenditure	-15Cr	-43Cr	-24Cr	-12Cr	-14Cr
Sale of Property, Plant, and Equipment	25.95T	25.49T	-	-	-
Investment in Marketable and Equity Securities, Total	-	-	-309.56Cr	-15Cr	27Cr
Other Investing Activities, Total	42.53L	-1.16Cr	2.14Cr	-70.47L	3.48Cr
Cash from Investing	-15Cr	-45Cr	-331.68Cr	-28Cr	17Cr
Short Term Debt Issued, Total	-	10L	-	-	-
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	10L	-	-	-
Short Term Debt Repaid, Total	-	-10L	-	-	-
Long-Term Debt Repaid, Total	-	-	-	-	-
Total Debt Repaid	-	-10L	-	-	-
Issuance of Common Stock	-	-	356.78Cr	-	-
Common Dividends Paid	-7.08Cr	-	-13Cr	-14Cr	-8.09Cr
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-7.08Cr	-	-13Cr	-14Cr	-8.09Cr
Other Financing Activities, Total	-1.08Cr	52.19L	-1.47Cr	-	-1.76Cr
Cash from Financing	-8.16Cr	52.19L	341.82Cr	-14Cr	-9.85Cr
Foreign Exchange Rate Adjustments	-45.9L	-11.89L	2.49Cr	13.78L	28.12L
Net Change in Cash	-1.63Cr	20Cr	21Cr	-36Cr	5.63Cr
Supplemental Items
Cash Interest Paid	-	943	-	-	-
Cash Income Tax Paid (Refund)	29.9L	29.28L	-4.06Cr	-5.2Cr	-5.67Cr
Levered Free Cash Flow	7.12Cr	15Cr	-43Cr	-12Cr	-40Cr
Unlevered Free Cash Flow	7.12Cr	15Cr	-43Cr	-12Cr	-40Cr
Change In Net Working Capital	-3.12Cr	-17Cr	25Cr	1.6Cr	33Cr
Net Debt Issued / Repaid	-	0	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	26.81	31.89	0.59	-0.77	0.1
Return on Total Capital	40.78	49.53	0.67	-0.81	0.11
Return On Equity %	54.21	68.85	5.78	1.29	2.33
Return on Common Equity	54.21	68.85	5.78	1.29	2.33
Margin Analysis
Gross Profit Margin %	42.03	41.87	13.03	2.81	10.87
SG&A Margin	1.78	1.12	3.01	4.01	3.51
EBITDA Margin %	37.9	38.31	10.27	0.05	10.37
EBITA Margin %	35.83	36.83	4.69	-11.65	1.24
EBIT Margin %	35.74	36.78	4.53	-11.87	1.08
Income From Continuing Operations Margin %	29.7	31.96	24.25	11.79	14.72
Net Income Margin %	29.7	31.96	24.25	11.79	14.72
Net Avail. For Common Margin %	29.7	31.96	24.25	11.79	14.72
Normalized Net Income Margin	21.6	22.81	16.06	7.55	11.07
Levered Free Cash Flow Margin	9.09	8.74	-64.14	-23.31	-55.54
Unlevered Free Cash Flow Margin	9.09	8.74	-64.14	-23.31	-55.54
Asset Turnover
Asset Turnover	1.2	1.39	0.21	0.1	0.15
Fixed Assets Turnover	2.56	2.95	0.78	0.51	0.7
Receivables Turnover (Average Receivables)	13.76	15.46	6.81	7.31	6.87
Inventory Turnover (Average Inventory)	7.96	10.8	5.62	4.83	5.14
Short Term Liquidity
Current Ratio	1.46	1.43	3.23	1.44	13.9
Quick Ratio	1.18	1.2	2.66	0.92	13.26
Operating Cash Flow to Current Liabilities	0.84	1.14	0.41	0.26	-0.06
Days Sales Outstanding (Average Receivables)	26.6	23.6	53.56	49.92	53.26
Days Outstanding Inventory (Average Inventory)	45.99	33.8	64.96	75.6	71.15
Average Days Payable Outstanding	152.55	140.09	232.05	145.43	104.37
Cash Conversion Cycle (Average Days)	-79.96	-82.69	-113.53	-19.91	20.04
Long Term Solvency
Total Debt/Equity	-	-	-	-	-
Total Debt / Total Capital	-	-	-	-	-
Total Liabilities / Total Assets	34.74	36.03	5.12	5.66	6.54
EBIT / Interest Expense	-	7L	-	-	-
EBITDA / Interest Expense	-	7L	-	-	-
(EBITDA - Capex) / Interest Expense	-	2L	-	-	-
Total Debt / EBITDA	-	-	-	-	-
Net Debt / EBITDA	-0.76	-0.8	-7.06	-406.42	-38.29
Total Debt / (EBITDA - Capex)	-	-	-	-	-
Net Debt / (EBITDA - Capex)	-1.55	-2.49	2.82	0.89	41.72
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	64.27	113.91	-59.71	-25.99	42.72
Gross Profit, 1 Yr. Growth %	51.03	113.08	-87.46	-84.05	452.6
EBITDA, 1 Yr. Growth %	63.07	116.28	-89.2	-99.61	22.69T
EBITA, 1 Yr. Growth %	63.25	119.89	-94.87	-283.57	-115.15
EBIT, 1 Yr. Growth %	63.23	120.17	-95.04	-293.87	-113
Earnings From Cont. Operations, 1 Yr. Growth %	70.62	130.21	-69.43	-64.03	87.47
Net Income, 1 Yr. Growth %	70.62	130.21	-69.43	-64.03	87.47
Normalized Net Income, 1 Yr. Growth %	56.38	125.93	-71.63	-65.24	109.45
Diluted EPS Before Extra, 1 Yr. Growth %	64.29	130.01	-76.77	-64.63	85.71
Accounts Receivable, 1 Yr. Growth %	71.44	99.31	-63.84	58.34	51.2
Inventory, 1 Yr. Growth %	48.58	64.44	-13.72	7.81	36.78
Net Property, Plant and Equip., 1 Yr. Growth %	47.54	111.53	23.67	3.6	6.08
Total Assets, 1 Yr. Growth %	49.19	109.13	198.01	-1.22	-0.05
Tangible Book Value, 1 Yr. Growth %	51.2	107.64	358.95	-1.78	-0.95
Common Equity, 1 Yr. Growth %	46.46	105	342.04	-1.79	-0.97
Cash From Operations, 1 Yr. Growth %	45.68	195.39	-86.88	-31.99	-123.82
Capital Expenditures, 1 Yr. Growth %	7.84	186.22	-44.13	-49.32	15.27
Levered Free Cash Flow, 1 Yr. Growth %	350.7	105.67	-395.52	-73.1	240.05
Unlevered Free Cash Flow, 1 Yr. Growth %	350.7	105.67	-395.52	-73.1	240.05
Dividend Per Share, 1 Yr. Growth %	-	42.85	4.99	-64.29	460
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	63.71	87.46	-7.17	-45.4	2.78
Gross Profit, 2 Yr. CAGR %	74.86	79.39	-48.32	-85.86	-6.11
EBITDA, 2 Yr. CAGR %	88	87.8	-51.68	-97.96	3.26
EBITA, 2 Yr. CAGR %	90.81	89.47	-66.41	-69.29	-47.29
EBIT, 2 Yr. CAGR %	91.05	89.58	-66.95	-68.98	-49.8
Earnings From Cont. Operations, 2 Yr. CAGR %	84.82	98.19	-16.11	-66.84	-19.93
Net Income, 2 Yr. CAGR %	84.82	98.19	-16.11	-66.84	-19.93
Normalized Net Income, 2 Yr. CAGR %	85.79	87.97	-19.94	-68.6	-14.67
Diluted EPS Before Extra, 2 Yr. CAGR %	81.26	94.39	-26.87	-71.34	-20.37
Accounts Receivable, 2 Yr. CAGR %	36.16	84.85	-15.11	-24.34	54.73
Inventory, 2 Yr. CAGR %	85.43	56.31	19.12	-3.55	21.44
Net Property, Plant and Equip., 2 Yr. CAGR %	64.73	76.66	61.74	13.19	4.83
Total Assets, 2 Yr. CAGR %	67.16	76.64	149.65	71.57	-0.67
Tangible Book Value, 2 Yr. CAGR %	71.26	77.19	208.7	112.31	-1.4
Common Equity, 2 Yr. CAGR %	68.54	73.28	201.03	108.36	-1.41
Cash From Operations, 2 Yr. CAGR %	82.22	107.44	-37.74	-70.12	-59.75
Capital Expenditures, 2 Yr. CAGR %	76.61	75.68	26.45	-46.79	-23.57
Levered Free Cash Flow, 2 Yr. CAGR %	117.94	204.46	146.54	-10.84	-4.36
Unlevered Free Cash Flow, 2 Yr. CAGR %	117.94	204.46	146.54	-10.84	-4.36
Dividend Per Share, 2 Yr. CAGR %	164.52	-	22.47	-38.76	41.42
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	86.39	78.98	12.28	-13.92	-24.78
Gross Profit, 3 Yr. CAGR %	105.46	86.77	-26.11	-65.07	-52.01
EBITDA, 3 Yr. CAGR %	128.17	96.99	-27.52	-90.34	-51.35
EBITA, 3 Yr. CAGR %	133.17	100.05	-43.1	-40.81	-75.74
EBIT, 3 Yr. CAGR %	134.33	100.3	-43.71	-40.39	-76.79
Earnings From Cont. Operations, 3 Yr. CAGR %	131.67	98.86	6.29	-36.74	-41.91
Net Income, 3 Yr. CAGR %	131.67	98.86	6.29	-36.74	-41.91
Normalized Net Income, 3 Yr. CAGR %	132.42	98.31	0.07	-39.38	-40.89
Diluted EPS Before Extra, 3 Yr. CAGR %	125.74	96.24	-4.22	-42.6	-47.19
Accounts Receivable, 3 Yr. CAGR %	45.5	54.6	7.3	4.5	-4.7
Inventory, 3 Yr. CAGR %	99.64	78.15	28.22	15.22	8.36
Net Property, Plant and Equip., 3 Yr. CAGR %	66.99	79.05	56.86	39.42	10.77
Total Assets, 3 Yr. CAGR %	62.79	80.12	110.28	83.28	43.27
Tangible Book Value, 3 Yr. CAGR %	68.95	82.62	143.34	110.74	64.63
Common Equity, 3 Yr. CAGR %	63.9	79.91	136.76	107.23	62.57
Cash From Operations, 3 Yr. CAGR %	120.6	114.06	-17.34	-35.88	-72.3
Capital Expenditures, 3 Yr. CAGR %	47.44	107.45	19.91	-6.77	-31.15
Levered Free Cash Flow, 3 Yr. CAGR %	-	113.77	201.45	17.8	39.3
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	113.77	201.45	17.8	39.3
Dividend Per Share, 3 Yr. CAGR %	91.27	115.41	-	-18.79	28.06
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	81.21	-	41.03	11.32	8.38
Gross Profit, 5 Yr. CAGR %	114.43	-	18.3	-33.48	-18.68
EBITDA, 5 Yr. CAGR %	144	-	22.63	-68.33	-16.49
EBITA, 5 Yr. CAGR %	158.14	-	7.43	-5.47	-44.8
EBIT, 5 Yr. CAGR %	166.5	-	7.05	-5.02	-46.23
Earnings From Cont. Operations, 5 Yr. CAGR %	157.94	-	54.32	-2.87	-5.09
Net Income, 5 Yr. CAGR %	157.94	-	54.32	-2.87	-5.09
Normalized Net Income, 5 Yr. CAGR %	168.14	-	51.75	-5.12	-6.11
Diluted EPS Before Extra, 5 Yr. CAGR %	133.9	-	43.81	-9.08	-11.04
Accounts Receivable, 5 Yr. CAGR %	77.74	-	17.29	16.17	24.22
Inventory, 5 Yr. CAGR %	50.35	-	62.38	39.38	25.46
Net Property, Plant and Equip., 5 Yr. CAGR %	75.55	-	64.87	49.04	33.51
Total Assets, 5 Yr. CAGR %	63.47	-	93.16	76.65	55.78
Tangible Book Value, 5 Yr. CAGR %	82.08	-	115.02	93.96	69.54
Common Equity, 5 Yr. CAGR %	65.45	-	109.02	90.79	66.77
Cash From Operations, 5 Yr. CAGR %	87.03	-	33	-2.62	-38.02
Capital Expenditures, 5 Yr. CAGR %	74.33	-	38.66	20.38	0.15
Levered Free Cash Flow, 5 Yr. CAGR %	68.46	-	-	50.67	90.45
Unlevered Free Cash Flow, 5 Yr. CAGR %	70.54	-	-	50.67	90.45
Dividend Per Share, 5 Yr. CAGR %	-	-	60.03	30.25	-